BBA
MRK icon

Braun-Bostich & Associates’s Merck MRK Stock Holding History

Braun-Bostich & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371K Sell
2,891
-363
-11% -$42.5K 0.21% 78
2026
Q1 		$391K Sell
3,254
-153
-4% -$17.7K 0.25% 69
2025
Q4 		$359K Buy
3,407
+312
+10% +$29.3K 0.22% 76
2025
Q3 		$260K Buy
3,095
+204
+7% +$16.8K 0.16% 96
2025
Q2 		$229K Buy
2,891
+5
+0.2% +$397 0.16% 105
2025
Q1 		$259K Buy
2,886
+6
+0.2% +$560 0.19% 89
2024
Q4 		$287K Sell
2,880
-176
-6% -$18.1K 0.21% 80
2024
Q3 		$347K Sell
3,056
-259
-8% -$30.8K 0.24% 70
2024
Q2 		$410K Buy
3,315
+440
+15% +$56.7K 0.31% 60
2024
Q1 		$379K Sell
2,875
-331
-10% -$40.8K 0.32% 76
2023
Q4 		$350K Buy
+3,206
New +$333K 0.32% 78
2023
Q3 		– Sell
-2,864
Closed -$330K – 88
2023
Q2 		$330K Buy
2,864
+408
+17% +$46.3K 0.71% 53
2023
Q1 		$261K Buy
2,456
+336
+16% +$36.3K 0.62% 58
2022
Q4 		$235K Buy
+2,120
New +$217K 0.68% 51
2020
Q4 		– Sell
-2,855
Closed -$226K – 154
2020
Q3 		$226K Sell
2,855
-3,218
-53% -$252K 0.22% 80
2020
Q2 		$448K Hold
6,073
– – 0.44% 39
2020
Q1 		$428K Sell
6,073
-163
-3% -$12.8K 0.55% 38
2019
Q4 		$548K Sell
6,236
-136
-2% -$11.2K 0.54% 38
2019
Q3 		$512K Buy
6,372
+907
+17% +$72.7K 0.6% 31
2019
Q2 		$437K Buy
5,465
+1,684
+45% +$129K 0.46% 36
2019
Q1 		$300K Buy
3,781
+2,136
+130% +$160K 0.31% 80
2018
Q4 		$120K Hold
1,645
– – 0.13% 126
2018
Q3 		$111K Hold
1,645
– – 0.11% 132
2018
Q2 		$95K Hold
1,645
– – 0.1% 140
2018
Q1 		$86K Sell
1,645
-894
-35% -$48.3K 0.07% 140
2017
Q4 		$136K Buy
+2,539
New +$141K 0.12% 124

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Braun-Bostich & Associates's MRK Position: Q2 2026 in Review

Braun-Bostich & Associates reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $42.5K and leaving 2,891 shares worth $371K. The position accounts for 0.21% of the portfolio, ranked #78.

Braun-Bostich & Associates first reported a position in MRK in Q4 2017 and has held it in 26 quarters since. The position peaked at $548K in Q4 2019. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Braun-Bostich & Associates held 2,891 shares of Merck worth $371K as of Q2 2026.
  • Braun-Bostich & Associates sold 363 Merck shares in Q2 2026, an estimated $42.5K.
  • Merck made up 0.21% of Braun-Bostich & Associates's portfolio in Q2 2026, its #78 holding.
  • Braun-Bostich & Associates first reported a position in Merck in Q4 2017 and has held it in 26 quarters since.
  • Braun-Bostich & Associates's Merck position peaked at $548K in Q4 2019.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Braun-Bostich & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.